HOSPITAL UNIVERSITARIO RUBER
Departamento
University of Pisa
Pisa, ItaliaPublicaciones en colaboración con investigadores/as de University of Pisa (2)
2016
-
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Annals of Oncology, Vol. 27, Núm. 11, pp. 2046-2052